Beclobrate

Beclobrate 구조식 이미지
카스 번호:
55937-99-0
상품명:
Beclobrate
동의어(영문):
Turec;Beclipur;Sgd-24774;Beclobrate;Beclobrate USP/EP/BP;Ethyl 2-(4-(4-chlorobenzyl)phenoxy)-2-Methylbutanoate;Ethyl(±)-2-[[α(-(4-chlorophenyl)-4-tolyl]oxy]-2-methylbutyrate;2-[4-(4-Chlorobenzyl)phenoxy]-2-methylbutyric acid ethyl ester;Butanoic acid, 2-[4-[(4-chlorophenyl)Methyl]phenoxy]-2-Methyl-, ethyl ester
CBNumber:
CB6875424
분자식:
C20H23ClO3
포뮬러 무게:
346.85
MOL 파일:
55937-99-0.mol

Beclobrate 속성

끓는 점
bp0.01-0.1 200-204°
저장 조건
2-8°C

안전

독성 LD50 orally in mice: 8000 mg/kg (Thiele, 1979)

Beclobrate C화학적 특성, 용도, 생산

개요

Beclobrate is a hypolipidemic agent related structurally to clofibrate. It is reportedly useful in types IIa-V hyperlipoproteinemias, promoting normalization of t h e atherogenic index.

World Health Organization (WHO)

Beclobrate, an antihyperlipidaemic agent, was introduced into medicine in 1985. Although a causal relationship between the use of the drug and hepatic toxicity has not been established, the Intercantonal Office for the Control of Medicines has withdrawn marketing authorization since safer therapeutic alternatives are available. Beclobrate is not registered elsewhere.

Beclobrate 준비 용품 및 원자재

원자재

준비 용품


Beclobrate 공급 업체

글로벌( 17)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32760 60
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 8930 58
Hangzhou Sage Chemical Co., Ltd. +86057186818502 13588463833
info@sagechem.com China 10269 58
SPIRO PHARMA
eric_feng1954@126.com China 9254 55
Aikon International Limited 025-66113011 18112977050
cb6@aikonchem.com China 15495 58
Angel Pharmatech, Ltd. 17317130613
3358272972@qq.com China 3249 58
Chengdu Saint - Kay Biotechnology Co., Ltd. 028-85157043 15882256948
676046971@qq.com China 4394 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 23963 58
Shaanxi Istare Biotechnology Co., Ltd. 18682931470
2142355700@qq.com China 2519 58

Copyright 2019 © ChemicalBook. All rights reserved